Patents

Description

COMPUŞI INHIBITORI, IREVERSIBILI, AI TIROZIN KINAZELOR, COMPOZIŢIE FARMACEUTICĂ CARE ÎI CONŢINE ŞI UTILIZAREA ACESTORA

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO121900

Date: 30.07.2008

Inventor(s):

BRIDGES ALEXANDER JAMES [US]

DENNY WILLIAM ALEXANDER [NZ]

DOBRUSIN ELLEN MYRA [US]

DOHERTY ANNETTE MARIAN [US]

FRY DAVID W [US]

MCNAMARA DENNIS JOSEPH [US]

SHOWALTER HOWARD DANIEL HOLLIS [US]

SMAILL JEFFREY B [NZ]

ZHOU HAIRONG [US]

Applicant(s):
WARNER LAMBERT CO [US]
Classification:
International patent classification (IPC):
A61K31/00; A61K31/505; A61K31/517; A61K31/519; A61K31/529; A61P15/00; A61P17/06; A61P35/00; A61P43/00; A61P9/10; C07D239/94; C07D403/04; C07D471/04; C07D487/04; C07D495/04; C07D521/00; C07F9/6561
Cooperative patent classification (CPC):
A61P15/00 (EP); A61P17/06 (EP); A61P25/00 (EP); A61P35/00 (EP); A61P43/00 (EP); A61P9/10 (EP); C07D231/12 (EP, US); C07D233/56 (EP, US); C07D239/94 (EP, US); C07D249/08 (EP, US); C07D403/04 (EP, US); C07D471/04 (EP, US); C07D487/04 (EP, US); C07D495/04 (EP, US); C07F9/6561 (EP, US)
Application info:
No.: RO19980001475
Date: 08.04.1997
Priority number(s):
US19960015351P 12.04.1996 ; WO1997US05778 08.04.1997
Related patents:
ATE213730; AU2446397; AU725533; BG102811; BG63160; BR9708640; CA2249446; CN100503580; CN1145614; CN1218456; CN1495172; CN1923818; CZ295468; CZ324498; DE69710712; DK0892789; EA001595; EA199800887; EE05289; EE9800328; EP0892789; ES2174250; GEP20012442; HK1019739; HK1064675; HU228446; HU9901207; JP2000508657; JP3370340; NO312588; NO984718; NZ332119; PL190489; PL329391; PT892789; SI0892789; SK141798; SK284073; US2003229051; US6344459; US6602863; US7786131; WO9738983; ZA973060
Description:

Invenţia se referă la compu?i, reprezentaţi de formula I: care sunt inhibitori ireversibili ai tirozin kinazelor, la compoziţii farmaceutice care conţin ace?ti compu?i ?i la utilizarea acestora pentru tratarea cancerului, aterosclerozei, restenozei, endometiozei ?i psoriazisului.

Share this on:
Facebook Twitter/X LinkedIn Whatsapp Email